Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 641 to 650 of 1584 total matches.

Topical Terbinafine for Tinea Infections

   
The Medical Letter on Drugs and Therapeutics • Aug 20, 1993  (Issue 903)
corporis. The Medical Letter, Vol. 35 (Issue 903) August 20, 1993, pp. 76-78 Copyright  The Medical ...
Terbinafine 1% cream (Lamisil - Sandoz), an allylamine synthetic antifungal drug chemically related to naftifine (Naftin - Medical Letter, 30:98, 1988), is now available in the USA for topical treatment of tinea pedis, tinea cruris, and tinea corporis infections. An oral formulation is available in Europe and is under investigation here.
Med Lett Drugs Ther. 1993 Aug 20;35(903):76-8 |  Show IntroductionHide Introduction

Corneal Surgery for Myopia

   
The Medical Letter on Drugs and Therapeutics • Oct 15, 1993  (Issue 907)
, other complications, such The Medical Letter, Vol. 35 (Issue 907) October 15, 1993, pp. 95-96 Copyright ...
Readers have inquired about the effectiveness and safety of operations on the cornea to correct refractive errors and restore normal vision without glasses or contact lenses. Several different operations are now being used for this purpose.
Med Lett Drugs Ther. 1993 Oct 15;35(907):95-6 |  Show IntroductionHide Introduction

Famciclovir for Herpes Zoster

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 1994  (Issue 934)
between groups in The Medical Letter, Vol. 36 (Issue 934) October 28, 1994, pp. 97-98 Copyright ...
Famciclovir (Famvir - SmithKline Beecham) is now available in the USA for oral treatment of acute uncomplicated herpes zoster (shingles). The manufacturer claims that use of the drug reduces the duration of postherpetic neuralgia. Famciclovir is similar to acyclovir (Zovirax - Burroughs Wellcome), which has been the drug of choice for treatment of varicella-zoster and herpes simplex virus infections (Medical Letter, 36:27, 1994).
Med Lett Drugs Ther. 1994 Oct 28;36(934):97-8 |  Show IntroductionHide Introduction

Fluticasone Propionate Nasal Spray for Allergic Rhinitis

   
The Medical Letter on Drugs and Therapeutics • Jan 20, 1995  (Issue 940)
Letter, Vol. 37 (Issue 940) January 20, 1995, pp. 5-6 Copyright  The Medical Letter UNAUTHORIZED ...
An intranasal spray formulation of the corticosteroid fluticasone propionate (floo tik a sone; Flonase - Allen & Hanburys) has been approved by the US Food and Drug Administration for treatment of seasonal and perennial allergic rhinitis in adults and children more than 12 years old.
Med Lett Drugs Ther. 1995 Jan 20;37(940):5-6 |  Show IntroductionHide Introduction

Grapefruit Juice Interactions With Drugs

   
The Medical Letter on Drugs and Therapeutics • Aug 18, 1995  (Issue 955)
The Medical Letter, Vol. 37 (Issue 955) August 18, 1995, pp. 73-74 Copyright  The Medical Letter ...
In a study of the interaction between alcohol and the calcium-channel blocker felodipine (Plendil), the grapefruit juice vehicle for the alcohol appeared to increase felodipine plasma concentrations. Subsequent studies have found that grapefruit juice increases plasma concentrations of several calcium-channel blockers and of some other drugs as well (DG Bailey et al, Clin Pharmacokinet, 26:91, 1994).
Med Lett Drugs Ther. 1995 Aug 18;37(955):73-4 |  Show IntroductionHide Introduction

Ceftibuten - A New Oral Cephalosporin

   
The Medical Letter on Drugs and Therapeutics • Mar 15, 1996  (Issue 970)
resistant) to penicillin. In some areas of the USA, 25% or more of The Medical Letter, Vol. 38 (Issue 970 ...
Ceftibuten (Cedax - Schering), an oral cephalosporin similar to cefixime (Suprax - Medical Letter, 31:73, 1989), has been approved by the US Food and Drug Administration (FDA) for treatment of acute otitis media, pharyngitis or tonsillitis, and for acute bacterial exacerbations of chronic bronchitis.
Med Lett Drugs Ther. 1996 Mar 15;38(970):23-4 |  Show IntroductionHide Introduction

Fosfomycin for Urinary Tract Infections

   
The Medical Letter on Drugs and Therapeutics • Jul 18, 1997  (Issue 1005)
and 800 mg sulfamethoxazole. The Medical Letter, Vol. 39 (Issue 1005) July 18, 1997, pp. 66-68 Copyright ...
Fosfomycin, a broad-spectrum antibiotic used parenterally in Europe for many years, has been approved by the US Food and Drug Administration (FDA) as fosfomycin tromethamine (Monurol - Forest) for single-dose oral treatment of uncomplicated urinary tract infections in women.
Med Lett Drugs Ther. 1997 Jul 18;39(1005):66-8 |  Show IntroductionHide Introduction

Cholesterol-lowering margarine

   
The Medical Letter on Drugs and Therapeutics • Jun 18, 1999  (Issue 1055)
margarine produced a further LDL cholesterol reduction of 16% The Medical Letter, Vol. 41 (Issue 1055) June ...
Two cholesterol-lowering margarines have been marketed in the USA.
Med Lett Drugs Ther. 1999 Jun 18;41(1055):56-8 |  Show IntroductionHide Introduction

Sirolimus (Rapamune) for Transplant Rejection

   
The Medical Letter on Drugs and Therapeutics • Feb 07, 2000  (Issue 1071)
Street, New Rochelle, N.Y. 10801 • A Nonprofit Publication Vol. 42 (W1071C) February 7, 2000 ...
Sirolimus, whlch is structurally related to tacrolimus, has been approved by the FDA for prevention of acute renal transplant rejection. The manufacturer recommends that sirolimus be taken with cyclosporine and corticosteroids.
Med Lett Drugs Ther. 2000 Feb 7;42(1071):13-4 |  Show IntroductionHide Introduction

Bexarotene (Targretin) For Cutaneous T-cell Lymphoma

   
The Medical Letter on Drugs and Therapeutics • Apr 03, 2000  (Issue 1075)
Street, New Rochelle, N.Y. 10801 • A Nonprofit Publication Vol. 42 (W1075B) April 3, 2000 REPRODUCED ...
Bexarotene, a retinoid analog, has been approved by the US Food and Drug Administration for oral treatment of dermatologic manifestations of refractory cutaneous T-cell lymphoma.
Med Lett Drugs Ther. 2000 Apr 3;42(1075):31-2 |  Show IntroductionHide Introduction